Seborrheic Dermatitis Clinical Trial
Official title:
A Phase 2, Randomized, Vehicle and Ketoconazole-Controlled, Evaluator-Blinded, Study to Explore the Efficacy, Pharmacodynamics and Safety of Omiganan 1.75% Topical Gel BID in Patients With Mild to Moderate Facial Seborrheic Dermatitis
To explore the efficacy and pharmacodynamic effects of omiganan topical gel in facial seborrheic dermatitis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01703793 -
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT01203189 -
Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
|
N/A | |
| Completed |
NCT00991198 -
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
|
Phase 2 | |
| Completed |
NCT03567980 -
A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
|
Phase 4 | |
| Recruiting |
NCT01139749 -
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
|
Phase 4 | |
| Completed |
NCT05105139 -
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
|
||
| Completed |
NCT01591070 -
Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis
|
Phase 4 | |
| Completed |
NCT05787860 -
Ruxolitinib in Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT00403559 -
A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
|
Phase 2 | |
| Not yet recruiting |
NCT00767546 -
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
|
Phase 1 | |
| Recruiting |
NCT01315951 -
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
|
N/A | |
| Recruiting |
NCT05942248 -
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
|
N/A | |
| Recruiting |
NCT06013371 -
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
|
Phase 2 | |
| Recruiting |
NCT05319444 -
Cleansing Device for the Treatment of Scalp and Hair Conditions
|
N/A | |
| Completed |
NCT04445987 -
Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT04973228 -
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
|
Phase 3 | |
| Completed |
NCT03114111 -
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
|
Early Phase 1 | |
| Completed |
NCT02656368 -
Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
|
N/A | |
| Completed |
NCT00830908 -
HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis
|
N/A | |
| Completed |
NCT02349854 -
Neurobiology of the Scalp in Seborrheic Dermatitis
|
N/A |